DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Isoniazid; rifampinis the generic ingredient in two branded drugs marketed by Sanofi Aventis Us and Hikma Intl Pharms, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.
There are five drug master file entries for isoniazid; rifampin. One supplier is listed for this compound.
Recent Clinical Trials for isoniazid; rifampin
Identify potential brand extensions & 505(b)(2) entrants
|Fifth Affiliated Hospital, Sun Yat-Sen University||N/A|
|Andrew Dinardo||Phase 2|
|Celgene Corporation||Phase 2|
Pharmacology for isoniazid; rifampin
|Drug Class||Rifamycin Antibacterial |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Sanofi Aventis Us||RIFAMATE||isoniazid; rifampin||CAPSULE;ORAL||061884-001||Approved Prior to Jan 1, 1982||RX||No||Yes||Start Trial||Start Trial||Start Trial|
|Hikma Intl Pharms||RIFAMPIN AND ISONIAZID||isoniazid; rifampin||CAPSULE;ORAL||065221-001||Jul 29, 2005||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.